| RS1553766930 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1553767857 |
ATP2C1
|
Health Risk |
Pathogenic |
— |
| RS1553768038 |
ARHGAP31
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 1, Adams-Oliver syndrome 1 |
| RS1553768108 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1553768726 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1553768938 |
CASR
|
Health Risk |
Pathogenic |
— |
| RS1553768972 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1553768983 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1553768989 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1553769004 |
CASR
|
Health Risk |
Pathogenic |
— |
| RS1553769052 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1553769059 |
CASR
|
Health Risk |
Likely pathogenic |
CASR-related disorder, CASR-related disorder |
| RS1553769169 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Autosomal dominant hypocalcemia 1 |
| RS1553769428 |
HJV
|
Health Risk |
Pathogenic |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS1553769457 |
HJV
|
Health Risk |
Conflicting classifications of pathogenicity |
Hemochromatosis type 2A, Juvenile hemochromatosis |
| RS1553769459 |
HJV
|
Health Risk |
Pathogenic |
— |
| RS1553769576 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553769611 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1553769646 |
HJV
|
Health Risk |
Pathogenic |
— |
| RS1553769690 |
HJV
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS1553769735 |
HJV
|
Health Risk |
Pathogenic |
— |
| RS1553769745 |
HJV
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS1553769758 |
HJV
|
Health Risk |
Pathogenic |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS1553769886 |
HJV
|
Health Risk |
Pathogenic |
— |
| RS1553770003 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553770146 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553770178 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553770434 |
GATA2
|
Health Risk |
Likely pathogenic |
Monocytopenia with susceptibility to infections, Deafness-lymphedema-leukemia syndrome |
| RS1553770510 |
GATA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Leukemia, acute myeloid |
| RS1553770562 |
UBA5
|
Health Risk |
Pathogenic |
— |
| RS1553770577 |
UBA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 44 |
| RS1553770655 |
GATA2
|
Health Risk |
Likely pathogenic |
Monocytopenia with susceptibility to infections, Deafness-lymphedema-leukemia syndrome |
| RS1553770949 |
GATA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS1553770978 |
GATA2
|
Health Risk |
Likely pathogenic |
Monocytopenia with susceptibility to infections, Monocytopenia with susceptibility to infections |
| RS1553771050 |
GATA2
|
Health Risk |
Pathogenic |
— |
| RS1553771772 |
NPHP3
|
Health Risk |
Pathogenic |
— |
| RS1553771818 |
NPHP3
|
Health Risk |
Pathogenic |
— |
| RS1553772595 |
CLRN1
|
Health Risk |
Likely pathogenic |
Usher syndrome type 3A, Usher syndrome type 3A |
| RS1553773271 |
NPHP3
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Renal-hepatic-pancreatic dysplasia 1 |
| RS1553773296 |
NPHP3
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome and related disorders, Joubert syndrome and related disorders |
| RS1553774015 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1553774018 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1553774114 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1553774672 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS1553774884 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1553775177 |
SI
|
Health Risk |
Likely pathogenic |
Sucrase-isomaltase deficiency, Sucrase-isomaltase deficiency |
| RS1553775212 |
TTN
|
Health Risk |
Pathogenic |
CAP-congenital myopathy with arthrogryposis multiplex congenita without heart involvement, TTN-related myopathy |
| RS1553775392 |
NPHP3
|
Health Risk |
Likely pathogenic |
— |
| RS1553775581 |
ATP2C1
|
Health Risk |
Pathogenic |
— |
| RS1553775991 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553776036 |
CLRN1
|
Health Risk |
Pathogenic |
Usher syndrome type 3, Usher syndrome type 3 |
| RS1553776052 |
CLRN1
|
Health Risk |
Likely pathogenic |
Usher syndrome type 3A, Usher syndrome type 3A |
| RS1553776061 |
CLRN1
|
Health Risk |
Likely pathogenic |
Usher syndrome type 3A, Usher syndrome type 3A |
| RS1553776112 |
CLRN1
|
Health Risk |
Likely pathogenic |
Usher syndrome type 3A, Usher syndrome type 3A |
| RS1553776132 |
CLRN1
|
Health Risk |
Likely pathogenic |
Usher syndrome type 3A, Usher syndrome type 3A |
| RS1553776135 |
CLRN1
|
Health Risk |
Likely pathogenic |
Hearing impairment, Usher syndrome type 3A |
| RS1553776921 |
LAMB2
|
Health Risk |
Pathogenic |
LAMB2-related infantile-onset nephrotic syndrome, Pierson syndrome |
| RS1553777571 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1553777590 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1553778017 |
BCHE
|
Health Risk |
Likely pathogenic |
Deficiency of butyrylcholinesterase, Deficiency of butyrylcholinesterase |
| RS1553778044 |
BCHE
|
Health Risk |
Likely pathogenic |
Deficiency of butyrylcholinesterase, Deficiency of butyrylcholinesterase |
| RS1553778114 |
BCHE
|
Health Risk |
Likely pathogenic |
Deficiency of butyrylcholinesterase, Deficiency of butyrylcholinesterase |
| RS1553778179 |
BCHE
|
Health Risk |
Likely pathogenic |
Deficiency of butyrylcholinesterase, Deficiency of butyrylcholinesterase |
| RS1553778185 |
BCHE
|
Health Risk |
Likely pathogenic |
Deficiency of butyrylcholinesterase, Deficiency of butyrylcholinesterase |
| RS1553778198 |
BCHE
|
Health Risk |
Likely pathogenic |
Deficiency of butyrylcholinesterase, Deficiency of butyrylcholinesterase |
| RS1553778291 |
BCHE
|
Health Risk |
Likely pathogenic |
Deficiency of butyrylcholinesterase, Deficiency of butyrylcholinesterase |
| RS1553778865 |
PCCB
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1553778909 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1553778912 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1553778914 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1553779458 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1553779765 |
MASP1
|
Health Risk |
Pathogenic |
— |
| RS1553780163 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1553780501 |
MYLK
|
Health Risk |
Likely pathogenic |
Aortic aneurysm, familial thoracic 7 |
| RS1553780837 |
RHO
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1553781140 |
RHO
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 4, Retinal dystrophy |
| RS1553781176 |
RHO
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 4 |
| RS1553781304 |
MYLK
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 7 |
| RS1553781360 |
RHO
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinitis pigmentosa 4 |
| RS1553782108 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1553782747 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1553782779 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1553784569 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1553784684 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1553784721 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1553784921 |
PCCB
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1553784980 |
SLC2A2
|
Health Risk |
Pathogenic |
Fanconi-Bickel syndrome, Fanconi-Bickel syndrome |
| RS1553784985 |
OPA1
|
Health Risk |
Pathogenic |
Optic atrophy, Autosomal dominant optic atrophy classic form |
| RS1553785025 |
OPA1
|
Health Risk |
Pathogenic |
Autosomal dominant optic atrophy classic form, Autosomal dominant optic atrophy classic form |
| RS1553785033 |
SLC2A2
|
Health Risk |
Likely pathogenic |
Fanconi-Bickel syndrome, Fanconi-Bickel syndrome |
| RS1553785139 |
PCCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Propionic acidemia, Propionic acidemia |
| RS1553785222 |
MYLK
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 7 |
| RS1553785338 |
OPA1
|
Health Risk |
Pathogenic |
Optic atrophy, Optic atrophy |
| RS1553785362 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS1553785722 |
SLC2A2
|
Health Risk |
Pathogenic |
Fanconi-Bickel syndrome, Fanconi-Bickel syndrome |
| RS1553786361 |
SLC2A2
|
Health Risk |
Pathogenic |
Fanconi-Bickel syndrome, Fanconi-Bickel syndrome |
| RS1553786499 |
OPA1
|
Health Risk |
Likely pathogenic |
— |
| RS1553787619 |
MYLK
|
Health Risk |
Pathogenic |
Visceral myopathy 1, Megacystis-microcolon-intestinal hypoperistalsis syndrome 1 |
| RS1553787823 |
MYLK
|
Health Risk |
Pathogenic |
Visceral myopathy 1, Megacystis |
| RS1553787992 |
OPA1
|
Health Risk |
Pathogenic |
— |